phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with citric acid, anhydrous in 9 studies
| Studies (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Trials (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Recent Studies (post-2010) (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Studies (citric acid, anhydrous) | Trials (citric acid, anhydrous) | Recent Studies (post-2010) (citric acid, anhydrous) |
|---|---|---|---|---|---|
| 191 | 4 | 23 | 11,894 | 783 | 4,366 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giles, AR; Hoogendoorn, H; Nesheim, ME; Toh, CH | 1 |
| Anderson, GM; Cohen, DJ; Horne, WC | 1 |
| Chen, AB; Collen, D; Hopkins, A; Stump, DC; Topol, EJ | 1 |
| Danielsen, D; Rahr, HB; Sørensen, JV | 1 |
| Cattaneo, M; Falcon, CR; Ghidoni, A; Mannucci, PM | 1 |
| Beer, JH; Lassila, R; Lepäntalo, A; Siljander, P; Syrjälä, M | 1 |
| Kereiakes, DJ; Kukielka, G; Lorenz, T; Mueller, MN; Nanniazzi-Alaimo, L; Phillips, DR; Young, JJ | 1 |
| Batchelor, WB; Califf, RM; Cantor, WJ; Davidian, M; DiBattiste, PM; Dillard, P; Gretler, D; Harrington, RA; Huang, Y; Larsen, RL; Mantell, RM; Ohman, EM; Sketch, MH; Tcheng, JE; Tolleson, TR; Zhang, D; Zidar, JP | 1 |
| Grebe, M; Matzdorff, A; Pralle, H; Tillmanns, H; Voss, R | 1 |
1 trial(s) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and citric acid, anhydrous
| Article | Year |
|---|---|
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, an
Topics: Abciximab; Acute Disease; Aged; Amino Acid Chloromethyl Ketones; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Citric Acid; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine | 2002 |
8 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and citric acid, anhydrous
| Article | Year |
|---|---|
Alpha 2-macroglobulin binds and inhibits activated protein C.
Topics: alpha-Macroglobulins; Amino Acid Chloromethyl Ketones; Antithrombins; Binding Sites; Chemical Precipitation; Chromatography; Citrates; Citric Acid; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Humans; Immunoelectrophoresis; Kinetics; Methylamines; Protein C | 1991 |
Reproducibility and temporal stability of ADP-induced platelet aggregation: comparison of the anticoagulants sodium citrate and D-phenylalanyl-L-prolyl-L-arginyl-chloromethyl ketone.
Topics: Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Anticoagulants; Blood Preservation; Citrates; Citric Acid; Humans; Osmolar Concentration; Platelet Aggregation; Reproducibility of Results; Time Factors | 1991 |
Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activator.
Topics: Amino Acid Chloromethyl Ketones; Aprotinin; Blood Specimen Collection; Citrates; Citric Acid; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Myocardial Infarction; Tissue Plasminogen Activator | 1988 |
Markers of coagulation and fibrinolysis in blood drawn into citrate with and without D-Phe-Pro-Arg-Chloromethylketone (PPACK).
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Antithrombin III; Artifacts; Biomarkers; Blood Coagulation; Blood Specimen Collection; Citrates; Citric Acid; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Immunoenzyme Techniques; Molecular Sequence Data; Peptide Fragments; Peptide Hydrolases; Postoperative Period; Prothrombin | 1994 |
The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionized calcium.
Topics: Adult; Amino Acid Chloromethyl Ketones; Anticoagulants; Antithrombins; Blood Platelets; Calcium; Citrates; Citric Acid; Diabetes Mellitus; Humans; In Vitro Techniques; Middle Aged; Platelet Count; Thromboxane B2 | 1993 |
Variability in platelet responses to collagen--comparison between whole blood perfusions, traditional platelet function tests and PFA-100.
Topics: Adenosine Diphosphate; Adult; Aged; Amino Acid Chloromethyl Ketones; Anticoagulants; Blood Platelets; Citric Acid; Collagen; Drug Synergism; Epinephrine; Female; Genetic Variation; Humans; Integrins; Male; Middle Aged; Perfusion; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Polymorphism, Genetic; Receptors, Collagen; Reproducibility of Results; Rheology; Stress, Mechanical | 2001 |
Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban.
Topics: Abciximab; Amino Acid Chloromethyl Ketones; Antibodies, Monoclonal; Anticoagulants; Antithrombins; Blood Specimen Collection; Calcium; Chelating Agents; Citric Acid; Drug Interactions; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Tirofiban; Tyrosine | 2001 |
Pharmacodynamics of two different dosing regimens of tirofiban in citrate or PPACK anticoagulated blood.
Topics: Aged; Amino Acid Chloromethyl Ketones; Anticoagulants; Blood Platelets; Citric Acid; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Tirofiban; Tyrosine | 2005 |